2013
P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia
Uusküla A, Raag M, Abel-Ollo K, Talu A, Rüütel K, Salekesin M, Niccolai L, White T, Heimer R. P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia. Sexually Transmitted Infections 2013, 89: a218. DOI: 10.1136/sextrans-2013-051184.0682.Peer-Reviewed Original ResearchHSV-2 seroprevalenceDrug usersHSV-2 antibody testingSexual HIV transmission riskRisk behaviorsHerpes simplex virus type 2Current injection drug usersSimplex virus type 2HSV-2 seropositivityHSV-2 infectionHIV transmission riskPrevalence of HIVSexual risk reduction interventionInjection drug usersInjection risk behaviorsRisk reduction interventionsDrug use historyVirus type 2Sexual risk behaviorsHIV/AIDSRecent behavior changesHSV2 infectionSTI prevalenceActive IDUsHIV infection
2011
P1-S2.05 Clients of street-based female sex workers and potential bridging of HIV/STI in Russia
Niccolai L, Odinokova V, Safiullina L, Bodanovskaya Z, Heimer R, Levina O, Rusakova M. P1-S2.05 Clients of street-based female sex workers and potential bridging of HIV/STI in Russia. Sexually Transmitted Infections 2011, 87: a124. DOI: 10.1136/sextrans-2011-050108.62.Peer-Reviewed Original ResearchStreet-based female sex workersFemale sex workersInconsistent condom useMajority of clientsVaginal sexCondom useSex partnersFSW partnersGeneral populationClients of FSWsHIV/STI transmissionPilot studyPrevious HIV testHIV testing historyHIV/STIInjection drug usePrevalence of HIVSex workersHigh HIV prevalenceInjection drug usersHIV risk behaviorsConsistent condom useMale clientsConsumption of alcoholHIV testPrevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions
Beletsky L, Grau LE, White E, Bowman S, Heimer R. Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions. Drug And Alcohol Dependence 2011, 119: 145-149. PMID: 21705159, PMCID: PMC3192926, DOI: 10.1016/j.drugalcdep.2011.05.034.Peer-Reviewed Original ResearchConceptsSyringe exchange programsInjection drug usersNeedle stick injuriesCommunity-based prevention initiativesPublic health benefitsStick injuriesHIV transmissionPublic health rationaleDrug usersMost program managersMultivariate analysisSyringe possessionPrevention initiativesEvidence baseHealth benefitsCommunity healthOccupational healthHealth rationaleMultivariate modelingPrevalenceStructural interventionsSEP operationsPredictorsHealthPrevious year
2010
Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia
Abdala N, White E, Toussova OV, Krasnoselskikh TV, Verevochkin S, Kozlov AP, Heimer R. Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia. BMC Public Health 2010, 10: 676. PMID: 21054855, PMCID: PMC2988741, DOI: 10.1186/1471-2458-10-676.Peer-Reviewed Original ResearchConceptsInjection drug usersIDU sex partnersNon-IDUsRisky alcohol useSex partnersAlcohol useIDU populationSexual riskSexual transmissionUnprotected sexAlcohol Use Disorders Identification TestHIV prevention programsMultiple sexual partnersPatterns of alcoholSexual risk behaviorsSubstance use patternsDisorders Identification TestRisky sexual practicesHIV infectionMethamphetamine injectionAssessed associationsBackgroundTo dateCasual partnersGeneral populationDrug usersSurvival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users
Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users. The Journal Of Infectious Diseases 2010, 202: 984-990. PMID: 20726768, PMCID: PMC2932767, DOI: 10.1086/656212.Peer-Reviewed Original ResearchConceptsHepatitis C virusInjection drug usersDrug usersC virusHigh prevalenceInsulin syringesViable virusTuberculin syringesHCV infectivityResidual volumeReporter virusDay 1Prevention strategiesDay 7Microculture assayDay 63VirusLuciferase activitySyringesDegrees CPrevalenceVirus survivalSurvivalVirus decay ratesDaysDrug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability
Cepeda JA, Odinokova VA, Heimer R, Grau LE, Lyubimova A, Safiullina L, Levina OS, Niccolai LM. Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability. AIDS And Behavior 2010, 15: 1003-1010. PMID: 20872063, PMCID: PMC3112286, DOI: 10.1007/s10461-010-9816-7.Peer-Reviewed Original ResearchEstimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic
Niccolai LM, Verevochkin SV, Toussova OV, White E, Barbour R, Kozlov AP, Heimer R. Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic. European Journal Of Public Health 2010, 21: 613-619. PMID: 20798184, PMCID: PMC3180633, DOI: 10.1093/eurpub/ckq115.Peer-Reviewed Original ResearchConceptsInjection drug usersRetrospective cohort analysisHIV incidenceEnzyme immunoassayHIV epidemicCohort analysisDrug usersBED capture enzyme immunoassayHIV incident casesRecent HIV incidenceHigh HIV incidenceHIV prevention interventionsCross-sectional studyCapture enzyme immunoassayIncident infectionsIncident casesEstimate incidenceIndependent correlatesIncidence rateIncidence estimatesPrevention interventionsCurrent epidemic situationIncidenceVulnerable populationsLow specificityEstimation of the number of injection drug users in St. Petersburg, Russia
Heimer R, White E. Estimation of the number of injection drug users in St. Petersburg, Russia. Drug And Alcohol Dependence 2010, 109: 79-83. PMID: 20060238, PMCID: PMC2875272, DOI: 10.1016/j.drugalcdep.2009.12.010.Peer-Reviewed Original Research
2009
Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users
Grau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users. Harm Reduction Journal 2009, 6: 36. PMID: 20003518, PMCID: PMC2804675, DOI: 10.1186/1477-7517-6-36.Peer-Reviewed Original ResearchRisk reduction materialsSyringe exchange programsInjection drug usersHygiene suppliesDrug usersHealth promotion behaviorsAppropriate useHealth promotion materialsSEP clientsPrevention interventionsHepatitis riskBlood flowInjection practicesPromotion behaviorsInjection siteBrief interventionIntervention effectivenessIntervention packetInterventionPassive introductionPromotion materialsExchange programsOne-quarterSubstantial numberVerbal remindersHepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection
Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction 2009, 104: 1881-1890. PMID: 19712125, PMCID: PMC2763027, DOI: 10.1111/j.1360-0443.2009.02687.x.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis C virusRespondent-driven samplingPrevalent infectionMajority of IDUsHepatitis C virus infectionSustained virological responseC virus infectionRespondent-driven sampleAssociation of genotypesIDU communityVirological responseHCV infectionAntiviral therapyC virusGenotype 3aDrug injectionVirus infectionDrug injectorsBlood samplesHCV sequencesDrug usersEndemic infectionInfectionMolecular epidemiologyDrug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia
Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, Kozlov AP. Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia. Harm Reduction Journal 2009, 6: 22. PMID: 19646255, PMCID: PMC2731096, DOI: 10.1186/1477-7517-6-22.Peer-Reviewed Original ResearchHIV risk behaviorsHIV infectionHIV riskDrug usersClean syringesSex-related HIV risk behaviorsRisk behaviorsInjection drug usersDrug use categoriesDrug use groupHIV testingUnsafe injectionsHIV prevalenceSyringe sharingHIV epidemicNeighborhood of residenceConclusionThe typeDrug choicePlace of residenceDrug usePrevention programsYounger ageStudy participantsIntervention impactDifferent drugsPotential Bridges of Heterosexual HIV Transmission from Drug Users to the General Population in St. Petersburg, Russia: Is it Easy to be a Young Female?
Toussova O, Shcherbakova I, Volkova G, Niccolai L, Heimer R, Kozlov A. Potential Bridges of Heterosexual HIV Transmission from Drug Users to the General Population in St. Petersburg, Russia: Is it Easy to be a Young Female? Journal Of Urban Health 2009, 86: 121-130. PMID: 19533368, PMCID: PMC2705483, DOI: 10.1007/s11524-009-9364-5.Peer-Reviewed Original ResearchConceptsIDU sex partnersInjection drug usersSex partnersNon-IDUsGeneral populationDrug usersYoung femalesHeterosexual HIV transmissionEpidemic of HIVHIV diagnosisHIV transmissionSexual transmissionHIV preventionPotential bridgeFurther transmissionYoung womenAlcohol useConvenience sampleSignificant correlatesSignificant predictorsUrgent effortsFemalesEpidemicLast yearsLow levels
2008
High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia
Niccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP. High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia. AIDS And Behavior 2008, 14: 932-941. PMID: 18843531, PMCID: PMC3116648, DOI: 10.1007/s10461-008-9469-y.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-positive serostatusHIV prevalenceHIV testingDrug usersHuman immunodeficiency virus (HIV) prevalenceRecent doctor visitHigh HIV prevalenceUnsafe injectionsPositive serostatusDoctor visitsSerostatusHIVPrevalencePoor knowledgeVirus prevalenceLow knowledgeTesting patternsHistory/Adequate coverageCorrelatesInfectionVisitsMonthsEconomic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users
Hu Y, Grau LE, Scott G, Seal KH, Marshall PA, Singer M, Heimer R. Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users. American Journal Of Preventive Medicine 2008, 35: 25-32. PMID: 18541174, PMCID: PMC2483306, DOI: 10.1016/j.amepre.2008.03.028.Peer-Reviewed Original ResearchConceptsInjection drug usersSyringe exchange programsHBV vaccinationDrug usersHepatitis B vaccination coverageActive injection drug usersAcute HBV infectionHepatitis B infectionHepatitis B vaccineQuality-adjusted life yearsAbsence of vaccinationLocal health departmentsDifferent vaccination strategiesVaccination program costsB infectionHBV infectionB vaccineFirst doseVaccination scheduleVaccination coverageVaccination strategiesCost-saving strategyVaccination campaignHigh riskMedical costsSpatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission
Heimer R, Barbour R, Shaboltas AV, Hoffman IF, Kozlov AP. Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission. AIDS 2008, 22: 123-130. PMID: 18090400, PMCID: PMC2778790, DOI: 10.1097/qad.0b013e3282f244ef.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug usersReceptive syringe sharingRisk behavior dataHIV/AIDS epidemicRisky injection behaviorsSeronegative cohortsSeronegative individualsHeroin injectionHIV prevalenceHIV transmissionIncident casesSyringe sharingHIV epidemicVaccine studiesStudy populationDrug useResidential addressesStudy participantsEpidemiological analysisHIVPrevalenceAIDS epidemicDisease prevalenceCohortHepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination Campaign
Heimer R, Grau L, Singer M, Scott G, Marshall P, Hu Y, Seal K. Hepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination Campaign. Journal Of Drug Issues 2008, 38: 335-350. DOI: 10.1177/002204260803800114.Peer-Reviewed Original ResearchInjection drug usersVaccination ratesDrug usersHepatitis B virus (HBV) prevalencePast hepatitis B infectionHepatitis B virus infectionHispanic injection drug usersHepatitis B infectionHepatitis B vaccinationB virus infectionDoses of vaccineNon-Hispanic blacksCurrent drug useSyringe exchange programsNon-Hispanic whitesB vaccinationB infectionHepatitis infectionHepatitis BEffective vaccineVirus infectionStudy populationVaccination campaignHigh riskDrug use
2005
Lessons from the Field: From Research to Application in the Fight Against AIDS among Injection Drug Users in Three New England Cities
Singer M, Stopka T, Shaw S, Santelices C, Buchanon D, Teng W, Khooshnood K, Heimer R. Lessons from the Field: From Research to Application in the Fight Against AIDS among Injection Drug Users in Three New England Cities. Human Organization 2005, 64: 179-191. DOI: 10.17730/humo.64.2.ga5ebpqynpxayrb5.Peer-Reviewed Original Research
2003
MAINTAINING RESPECTABILITY AND RESPONSIBILITY: GENDERED LABOR PATTERNS AMONG WOMEN INJECTION DRUG USERS
Hofman N, Strenski T, Marshall P, Heimer R. MAINTAINING RESPECTABILITY AND RESPONSIBILITY: GENDERED LABOR PATTERNS AMONG WOMEN INJECTION DRUG USERS. Health Care For Women International 2003, 24: 794-807. PMID: 14742117, DOI: 10.1080/07399330390229966.Peer-Reviewed Original ResearchMeSH KeywordsAdaptation, PsychologicalAdultAgedChicagoFemaleFollow-Up StudiesGender IdentityHealth BehaviorHumansIncomeMiddle AgedNeedle SharingNursing Methodology ResearchQualitative ResearchRisk FactorsRisk Reduction BehaviorRisk-TakingSelf DisclosureSocial ResponsibilitySocial ValuesSocioeconomic FactorsSubstance Abuse, IntravenousSurveys and QuestionnairesUrban HealthWomenWork
2001
Can HIV-1-Contaminated Syringes Be Disinfected?
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected? JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487-494. DOI: 10.1097/00126334-200112150-00013.Peer-Reviewed Original ResearchCan HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users.
Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487. PMID: 11744839, DOI: 10.1097/00042560-200112150-00013.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-1Undiluted bleachDrug usersHIV-1 recoveryViable HIV-1HIV-1 transmissionHarm reduction interventionsEffectiveness of bleachNeedle exchangeReduction interventionsMicroculture assaySingle rinseSterile syringeSyringesInjection behaviorEducational programsMinimal contact time